CD274 and colorectal carcinoma: Programmed cell death protein 1 (PD-1) and its ligand PD-L1 have emerged as critical targets in immunotherapy for CRC, particularly in the context of microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) tumors.